DE EN

We establish innovative immunological approaches for the development of new therapies for dementia.
Novel
therapies
for dementia

Welcome to Linuslifescience

We detect early biomarker signals from the peripheral immune system of patients suffering from neurodegenerative diseases such as Alzheimer’s dementia. Our goal is to develop novel therapies for these diseases through innovative immunological approaches.

After many failed therapeutic approaches, immunological correlations are increasingly becoming the focus of recent research, including the hypothesis that progressive neurodegenerative processes leading to dementia are the result of age-related inflammation.

We work closely with leading clinicians in neurology, neurobiology, and immunology. With our expertise, we are building a bridge from the diagnostic basics and the monitoring of biomarkers to the development of new therapies.

“Satisfaction of one’s curiosity is one of the greatest sources of happiness in life.”

LINUS PAULING (1901–1994)

The American chemist is considered to be the founder of “quantum chemistry.” As a committed scientist, he placed the complexity of the human body at the center of his work. He was awarded the Nobel Prize in 1954 for his research into the molecular structure of proteins and the Nobel Peace Prize in 1962 for his great commitment against nuclear weapon tests. He taught at the California Institute of Technology and Stanford University. In 1973, he founded the Linus Pauling Institute of Science and Medicine in Palo Alto, California.

Management

Dr. Annegret Feuerhelm-Heidl

Managing Director

Dr. Annegret Feuerhelm-Heidl

Managing Director

Dr. Feuerhelm-Heidl is a graduate biologist, and worked in research and marketing at Novartis Neuroscience for many years. She founded the company Predemtec in 2011 and the successor company LinusLifeScience in 2019. Dr. Feuerhelm-Heidl has an extensive, international scientific network at her disposal.

Prof. Dr. med. Asmus Finzen

Medical Advisor

Prof. Dr. med. Asmus Finzen

Medical Advisor

Dr. Finzen is a psychiatrist, sociologist, and renowned scientific journalist. He taught at the Hanover Medical School and the University Hospital of Basel, and has published numerous papers on the prevention and early treatment of dementia. Dr. Finzen advises LinusLifeScience in all medical matters.

Dr. Patrick Scotton

Consultant

Dr. Patrick Scotton

Consultant

Dr. Scotton is a neurobiologist and holds a PhD from the Biozentrum of the University of Basel. The life science entrepreneur has many years of start-up, business development, and marketing experience. He was, among others, founder and CEO of Predemtec GmbH. Dr. Scotton has excellent contacts in the biotech and pharmaceutical scene.

Contact

Are you interested in learning more about us and our work?
We look forward to hearing from you!

LinusLifeScience

Robert-Rössle-Str. 10
13125 Berlin, Germany
Phone: +49 (0) 3 0 9489 2032
feuerhelm@linuslifescience.com
www.linuslifescience.com